Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Gross Margin (2016 - 2025)

Dexcom (DXCM) has disclosed Gross Margin for 16 consecutive years, with 62.93% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 404.0% to 62.93% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 60.1% through Dec 2025, down 36.0% year-over-year, with the annual reading at 60.1% for FY2025, 36.0% down from the prior year.
  • Gross Margin for Q4 2025 was 62.93% at Dexcom, up from 60.48% in the prior quarter.
  • The five-year high for Gross Margin was 70.09% in Q2 2021, with the low at 56.85% in Q1 2025.
  • Average Gross Margin over 5 years is 63.37%, with a median of 63.12% recorded in 2022.
  • The sharpest move saw Gross Margin soared 721bps in 2021, then tumbled -552bps in 2022.
  • Over 5 years, Gross Margin stood at 67.69% in 2021, then fell by -2bps to 66.4% in 2022, then dropped by -4bps to 63.47% in 2023, then fell by -7bps to 58.9% in 2024, then increased by 7bps to 62.93% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 62.93%, 60.48%, and 59.53% for Q4 2025, Q3 2025, and Q2 2025 respectively.